ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Promising new CAR-T therapy able to target T-cell lymphoma
November 16, 2017The CAR-T space has progressed rapidly over the last few years, culminating in FDA approvals for Novartis and Gilead to treat B-cell lymphomas; however... -
FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma
October 23, 2017The U.S. Food and Drug Administration approved Yescarta, a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment.
Pharma Sources Insight January 2025
